3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
3
Phase NA
1
Phase 4
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
8
Wilms Tumor
1
Recurrence
1
Patient Acceptance of Health Care
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Lymphoma, Large B-Cell, Diffuse
1
Carcinoma, Hepatocellular
1
Interventions
tislelizumab
1
lornoxicam
1
Patient Discharge
1
Ofloxacin
1
Mitomycin
1
Epirubicin
1
Drainage
1
Doxorubicin
1
BCG Vaccine
1
Accelerometry
1
5-aminolevulinic acid hexyl ester
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Non-Muscle Invasive Bladder Neoplasms
×
Epirubicin
×
Clear all
NCT02214602
2018-03-22
NMIBCIVT
Mansoura University
Phase 4
Completed
240 enrolled